Key Points

• Combination treatment for promoting neuroregeneration and suppressing inflammation
• May be used to treat neuronal damage caused by conditions such as stroke, Alzheimer's disease, ALS, MS, Parkinson's disease, traumatic brain injury,

Abstract

The University of Central Florida invention relates to a combination therapy to promote neuroregeneration consisting of 1) MS-818 to increase endogenous neural stem cells and 2) non-steroidal anti-inflammatory drugs to suppress inflammation